# NAVIGATE GRX Study

> **NCT04883008** · — · TERMINATED · sponsor: **Corindus Inc.** · enrollment: 50 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CorPath GRX with technIQ automated movements enabled (technIQ ON)
- **DEVICE:** CorPath GRX with technIQ automated movements disabled (technIQ OFF).

## Key facts

- **NCT ID:** NCT04883008
- **Lead sponsor:** Corindus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-14
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-07
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Sponsor business decision and low enrollment
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883008, "NAVIGATE GRX Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04883008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*